Treating precancerous skin lesions with topical targeted therapies may significantly reduce their size and inhibit the growth of cutaneous squamous cell carcinoma, the second most common form of cancer, suggests a new animal model study from the Perelman School of Medicine at the University of Pennsylvania.
↧